Abstract
The development of transplant arteriosclerosis, the hallmark feature of heart transplant rejection is associated with a chronic immune response and influenced by the initial injury caused by ischemia and reperfusion. As previously shown, donor treatment with a PHD-inhibitor activating Hypoxia-inducible transcription factors (HIFs) prevents graft injury and prolongs survival in an allogenic kidney transplant model. Therefore, the aim of this study was to investigate the effect of HIF activation with a PHD-inhibitor on transplant arteriosclerosis in an experimental aortic allograft model.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
